pimavanserin

Product NDC
72205-055
11-digit product format
722050055
Labeler code
72205
Product ID
72205-055_403b6540-c53d-4e92-91b4-36ca6338b2b1
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
pimavanserin
Dosage form
CAPSULE
Route
ORAL
Labeler
Novadoz Pharmaceuticals LLC
Application
ANDA214925
Marketing category
ANDA
Marketing start
2024-01-16
Substance
PIMAVANSERIN TARTRATE
Active strength
34 mg/1
Pharmacologic classes
Atypical Antipsychotic [EPC]
NDC exclude flag
No
Listing certified through
2026-12-31
Current FDA listing
Yes

Additional Listing Data#

Finished product
Yes
Brand name base
pimavanserin
Listing expiration
2026-12-31

Active Ingredients#

Ingredient, Strength table
IngredientStrength
PIMAVANSERIN TARTRATE34 mg/1

Harmonized Identifiers#

Field, Values table
FieldValues
UniiNA83F1SJSR
Rxcui2049275

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
1d8bd08a-e111-4068-8539-c934574f1a15Product name220180815

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
72205-055-30pimavanserin30 in 1 BOTTLECAPSULE301

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYDailyMedSPL version
2049275pimavanserin 34 MG Oral CapsulePSN403b6540-c53d-4e92-91b4-36ca6338b2b11
2049275pimavanserin 34 MG Oral CapsuleSCD403b6540-c53d-4e92-91b4-36ca6338b2b11
2049275pimavanserin 34 mg (as pimavanserin tartrate 40 MG) Oral CapsuleSY403b6540-c53d-4e92-91b4-36ca6338b2b11

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionStatus
72205-055-307220500553030 in 1 BOTTLEHistorical